PAFAH1B1 and breast carcinoma: To further explore the association of PAFAH1B1 with aggressive disease, we interrogated TCGA patient data and found that stratifying breast cancer patients into quartiles by PAFAH1B1 expression revealed a strong association between higher expression and worse overall survival (Fig. 1C).